SWK Holdings Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,447.00
12,059.00
17,576.00
16,161.00
27,199.00
25,885
Unusual Expense
-
-
6,638.00
8,077.00
8,509.00
7,875
Pretax Income
4,491.00
13,301.00
1,090.00
10,403.00
24,004.00
6,237
Consolidated Net Income
14,332.00
23,604.00
4,363.00
32,041.00
8,251.00
6,195
Net Income
12,862.00
20,765.00
7,370.00
28,888.00
3,047.00
6,195
Net Income After Extraordinaries
12,862.00
20,765.00
7,370.00
28,888.00
3,047.00
6,195
Net Income Available to Common
12,862.00
20,765.00
7,370.00
28,888.00
3,047.00
6,195
EPS (Basic)
3.10
3.20
0.57
2.22
0.23
0.47
Basic Shares Outstanding
4,134.30
6,485.50
12,986.00
13,015.00
13,036.00
13,051
EPS (Diluted)
3.11
3.20
0.57
2.22
0.23
0.47
Diluted Shares Outstanding
4,134.30
6,491.60
12,986.00
13,018.00
13,040.00
13,054
Minority Interest Expense
1,470.00
2,839.00
3,007.00
3,153.00
5,204.00
-
Total Expense
1,983.00
4,109.00
17,912.00
3,900.00
5,216.00
11,773
Operating Income
4,464.00
7,950.00
336.00
12,261.00
21,983.00
14,112
Income Taxes
9,841.00
10,303.00
3,273.00
21,638.00
15,753.00
42
Non-Operating Income (Expense)
49.00
5,351.00
5,884.00
6,219.00
10,530.00
-

About SWK Holdings

View Profile
Address
14755 Preston Road
Dallas Texas 75254
United States
Employees -
Website http://www.swkhold.com
Updated 07/08/2019
SWK Holdings Corp. engages in the business of financial and asset management in the field of pharmaceutical. The company offers capital and investments in life science companies, institutions and inventors. It engages in royalty purchases and financings, as well as commercialization of products.